Likewise, BRAF/NRAS mutant melanoma tumors contain several high-frequency driver mutations, and therefore represent a big challenge to dermatologists or oncologists in the discovery of unique and stable upregulated oncogenic markers among highly invasive melanoma samples for an early diagnosis and targeted therapy19,38,39. The gene discussed is BRAF; the disease is melanoma.